SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-18-020711
Filing Date
2018-04-16
Accepted
2018-04-16 16:02:04
Documents
2
Group Members
BRIAN D. GROSSMANCHRISTOPHER M. JAMESPARTNER FUND MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv491114_sc13g.htm SC 13G 153081
2 JOINT FILING AGREEMENT tv491114_ex99-1.htm EX-99.1 9027
  Complete submission text file 0001144204-18-020711.txt   164020
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Subject) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86096 | Film No.: 18756671
SIC: 2834 Pharmaceutical Preparations

Mailing Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111
Business Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111 415-281-1022
Partner Fund Management, L.P. (Filed by) CIK: 0001442756 (see all company filings)

IRS No.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G